Author

Lukas Hartl

LIVER DISEASE-ASSOCIATED ACE ACTIVITY IMPACTS ON FIBRINOLYSIS AND INFLAMMATION - A POTENTIAL LINK TO COVID-19
LIVER DISEASE-ASSOCIATED ACE ACTIVITY IMPACTS ON FIBRINOLYSIS AND INFLAMMATION - A POTENTIAL LINK TO COVID-19

Lukas Hartl

LIVER DISEASE-ASSOCIATED ACE ACTIVITY IMPACTS ON FIBRINOLYSIS AND INFLAMMATION - A POTENTIAL LINK TO COVID-19
LIVER DISEASE-ASSOCIATED ACE ACTIVITY IMPACTS ON FIBRINOLYSIS AND INFLAMMATION - A POTENTIAL LINK TO COVID-19

A BLOOD-BASED BIOMARKER PANEL PREDICTS RISK FOR ACUTE KIDNEY INJURY AND ACUTE-ON-CHRONIC LIVER FAILURE IN PATIENTS WITH CIRRHOSIS
A BLOOD-BASED BIOMARKER PANEL PREDICTS RISK FOR ACUTE KIDNEY INJURY AND ACUTE-ON-CHRONIC LIVER FAILURE IN PATIENTS WITH CIRRHOSIS

SEQUENTIAL CONSIDERATION OF VITRO SUBSTANTIALLY REDUCES THE DIAGNOSTIC AND PROGNOSTIC GREY ZONE OF THE BAVENO-VII CRITERIA FOR CLINICALLY SIGNIFICANT PORTAL HYPERTENSION
SEQUENTIAL CONSIDERATION OF VITRO SUBSTANTIALLY REDUCES THE DIAGNOSTIC AND PROGNOSTIC GREY ZONE OF THE BAVENO-VII CRITERIA FOR CLINICALLY SIGNIFICANT PORTAL HYPERTENSION

SUPPRESSION OF THE PITUITARY-ADRENAL AXIS AND PROGNOSTIC VALUE OF SERUM CORTISOL IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE
SUPPRESSION OF THE PITUITARY-ADRENAL AXIS AND PROGNOSTIC VALUE OF SERUM CORTISOL IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE

Lukas Hartl  et al.

A FIB-4/VITRO SEQUENCE ALLOWS FOR DIAGNOSIS OF COMPENSATED ADVANCED CHRONIC LIVER DISEASE AND RISK STRATIFICATION FOR CLINICALLY SIGNIFICANT PORTAL HYPERTENSION
A FIB-4/VITRO SEQUENCE ALLOWS FOR DIAGNOSIS OF COMPENSATED ADVANCED CHRONIC LIVER DISEASE AND RISK STRATIFICATION FOR CLINICALLY SIGNIFICANT PORTAL HYPERTENSION

Lukas Hartl  et al.

A BLOOD-BASED BIOMARKER PANEL PREDICTS RISK FOR ACUTE KIDNEY INJURY AND ACUTE-ON-CHRONIC LIVER FAILURE IN PATIENTS WITH CIRRHOSIS
A BLOOD-BASED BIOMARKER PANEL PREDICTS RISK FOR ACUTE KIDNEY INJURY AND ACUTE-ON-CHRONIC LIVER FAILURE IN PATIENTS WITH CIRRHOSIS

Lukas Hartl  et al.

SEQUENTIAL CONSIDERATION OF VITRO SUBSTANTIALLY REDUCES THE DIAGNOSTIC AND PROGNOSTIC GREY ZONE OF THE BAVENO-VII CRITERIA FOR CLINICALLY SIGNIFICANT PORTAL HYPERTENSION
SEQUENTIAL CONSIDERATION OF VITRO SUBSTANTIALLY REDUCES THE DIAGNOSTIC AND PROGNOSTIC GREY ZONE OF THE BAVENO-VII CRITERIA FOR CLINICALLY SIGNIFICANT PORTAL HYPERTENSION

Lukas Hartl  et al.

LIVER DISEASE-ASSOCIATED ACE ACTIVITY IMPACTS ON FIBRINOLYSIS AND INFLAMMATION - A POTENTIAL LINK TO COVID-19
LIVER DISEASE-ASSOCIATED ACE ACTIVITY IMPACTS ON FIBRINOLYSIS AND INFLAMMATION - A POTENTIAL LINK TO COVID-19

Lukas Hartl  et al.

CARVEDILOL INDUCES HIGHER HVPG RESPONSE RATES AND IS ASSOCIATED WITH LOWER RATES OF VARICEAL REBLEEDING THAN PROPRANOLOL IN SECONDARY PROPHYLAXIS OF PORTAL HYPERTENSION - A RETROSPECTIVE COHORT STUDY
CARVEDILOL INDUCES HIGHER HVPG RESPONSE RATES AND IS ASSOCIATED WITH LOWER RATES OF VARICEAL REBLEEDING THAN PROPRANOLOL IN SECONDARY PROPHYLAXIS OF PORTAL HYPERTENSION - A RETROSPECTIVE COHORT STUDY

Lukas Hartl  et al.

HEPATIC RECOMPENSATION ACCORDING TO BAVENO VII CRITERIA IS LINKED TO A CLEAR SURVIVAL BENEFIT IN PATIENTS WITH DECOMPENSATED ALCOHOL-RELATED CIRRHOSIS
HEPATIC RECOMPENSATION ACCORDING TO BAVENO VII CRITERIA IS LINKED TO A CLEAR SURVIVAL BENEFIT IN PATIENTS WITH DECOMPENSATED ALCOHOL-RELATED CIRRHOSIS

Lukas Hartl  et al.

ALCOHOL ABSTINENCE IMPROVES PROGNOSIS ACROSS ALL STAGES OF PORTAL HYPERTENSION IN ALCOHOL-RELATED CIRRHOSIS
ALCOHOL ABSTINENCE IMPROVES PROGNOSIS ACROSS ALL STAGES OF PORTAL HYPERTENSION IN ALCOHOL-RELATED CIRRHOSIS

Lukas Hartl  et al.

HIGH HISTAMINE LEVELS ASSOCIATE WITH ACUTE-ON-CHRONIC LIVER FAILURE AND LIVER-RELATED DEATH IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE
HIGH HISTAMINE LEVELS ASSOCIATE WITH ACUTE-ON-CHRONIC LIVER FAILURE AND LIVER-RELATED DEATH IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE

Lukas Hartl  et al.

ELIMINATE: A PCR RECORD-BASED HCV MACRO-ELIMINATION PROJECT IN AUSTRIA
ELIMINATE: A PCR RECORD-BASED HCV MACRO-ELIMINATION PROJECT IN AUSTRIA

Lukas Hartl  et al.

CLINICAL COURSE OF FURTHER DECOMPENSATION/MORTALITY IN PATIENTS WITH CIRRHOSIS AND ASCITES AS THE FIRST SINGLE DECOMPENSATION EVENT – AN INCEPTION COHORT STUDY
CLINICAL COURSE OF FURTHER DECOMPENSATION/MORTALITY IN PATIENTS WITH CIRRHOSIS AND ASCITES AS THE FIRST SINGLE DECOMPENSATION EVENT – AN INCEPTION COHORT STUDY

Lukas Hartl  et al.

VON WILLEBRAND FACTOR FOR OUTCOME PREDICTION WITHIN DIFFERENT CLINICAL STAGES OF ADVANCED CHRONIC LIVER DISEASE
VON WILLEBRAND FACTOR FOR OUTCOME PREDICTION WITHIN DIFFERENT CLINICAL STAGES OF ADVANCED CHRONIC LIVER DISEASE

Lukas Hartl  et al.

PERIPORTAL HYPERINTENSITY FACILITATES DIAGNOSIS OF PORTO-SINUSOIDAL VASCULAR DISORDER
PERIPORTAL HYPERINTENSITY FACILITATES DIAGNOSIS OF PORTO-SINUSOIDAL VASCULAR DISORDER

Lukas Hartl  et al.

ENDOSCOPIC VARICEAL BAND LIGATION IS SAFE DESPITE LOW PLATELET COUNT AND HIGH INR
ENDOSCOPIC VARICEAL BAND LIGATION IS SAFE DESPITE LOW PLATELET COUNT AND HIGH INR

Lukas Hartl  et al.

FACTOR VIII/PROTEIN C RATIO INDEPENDENTLY PREDICTS LIVER-RELATED EVENTS BUT DOES NOT REFLECT THE HYPERCOAGULABLE STATE IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE
FACTOR VIII/PROTEIN C RATIO INDEPENDENTLY PREDICTS LIVER-RELATED EVENTS BUT DOES NOT REFLECT THE HYPERCOAGULABLE STATE IN PATIENTS WITH ADVANCED CHRONIC LIVER DISEASE

Lukas Hartl  et al.

SAFETY OF DIRECT ORAL ANTICOAGULANTS (DOACS) IN PATIENTS WITH ADVANCED LIVER DISEASE
SAFETY OF DIRECT ORAL ANTICOAGULANTS (DOACS) IN PATIENTS WITH ADVANCED LIVER DISEASE

Lukas Hartl  et al.

Item 1 - 20 / 27
1
2